Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
1-(3',4'-Dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel gamma-secretase modulator, reduces brain beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease without causing peripheral toxicity.
J Pharmacol Exp Ther. 2007 Dec;323(3):822-30. doi: 10.1124/jpet.107.129007. Epub 2007 Sep 25.
J Pharmacol Exp Ther. 2007.
PMID: 17895400
Multi-target action of the novel anti-Alzheimer compound CHF5074: in vivo study of long term treatment in Tg2576 mice.
Sivilia S, Lorenzini L, Giuliani A, Gusciglio M, Fernandez M, Baldassarro VA, Mangano C, Ferraro L, Pietrini V, Baroc MF, Viscomi AR, Ottonello S, Villetti G, Imbimbo BP, Calzà L, Giardino L.
Sivilia S, et al. Among authors: baroc mf.
BMC Neurosci. 2013 Apr 5;14:44. doi: 10.1186/1471-2202-14-44.
BMC Neurosci. 2013.
PMID: 23560952
Free PMC article.
Item in Clipboard
Incidence and predictors of acute symptomatic seizures after stroke.
Beghi E, D'Alessandro R, Beretta S, Consoli D, Crespi V, Delaj L, Gandolfo C, Greco G, La Neve A, Manfredi M, Mattana F, Musolino R, Provinciali L, Santangelo M, Specchio LM, Zaccara G; Epistroke Group.
Beghi E, et al.
Neurology. 2011 Nov 15;77(20):1785-93. doi: 10.1212/WNL.0b013e3182364878. Epub 2011 Oct 5.
Neurology. 2011.
PMID: 21975208
Item in Clipboard
Cite
Cite